Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220021697 220005295 1.56 78 Curative (C) 2018-08-07 2019-01-15 AML Interim Guidelines FLAG-Ida N N 220020551 FLAG + IDARUBICIN
220021698 220012787 1.72 null Curative (C) 2017-02-12 2017-05-15 AML17 TRIAL N N 220020576 AML17 TRIAL
220021699 220005315 1.75 64.5 Palliative (P) 2014-03-26 2014-03-26 AML17 TRIAL N N 220020591 AML17 TRIAL
220021700 220005332 0 73 Adjuvant (A) 2013-11-24 2013-12-01 AML17 TRIAL Y N 220020646 AML17 TRIAL
220021701 220012808 1.7 70 null 2017-10-26 2018-01-29 AML17 TRIAL N N 220020649 AML17 TRIAL
220021702 220019362 1.73 51.4 Curative (C) 2014-04-18 2014-07-11 AML Interim Guidelines FLAG-Ida Y N 220020654 FLAG + IDARUBICIN
220021703 220005352 1.76 null Adjuvant (A) 2019-04-23 2019-04-23 AML17 TRIAL null N 220020673 AML17 TRIAL
220021704 220005360 1.7 87 Curative (C) 2014-04-16 2015-10-02 AML17 TRIAL N N 220020676 AML17 TRIAL
220021705 220005368 1.87 74.9 Disease modification (D) 2020-04-01 2020-07-08 FLAG + Idarubicin N null 220020695 FLAG + IDARUBICIN
220021706 220005389 1.61 53.1 Disease modification (D) 2017-03-19 2017-08-19 FLAG + Idarubicin 02 N 220020746 FLAG + IDARUBICIN
220021708 220005464 1.76 82.3 Curative (C) 2017-09-27 2017-10-01 FLAG + Idarubicin 01 N 220020990 FLAG + IDARUBICIN
220021710 220005510 1.85 108.4 Curative (C) 2019-03-25 2019-03-26 AML17 TRIAL Y N 220021137 AML17 TRIAL
220021711 220005523 1.69 78.1 Curative (C) 2018-04-29 2018-07-31 FLAG + Idarubicin N N 220021161 FLAG + IDARUBICIN
220021712 220005533 1.65 65.1 Curative (C) 2014-03-24 2014-03-24 AML 19 TRIAL N null 220021175 AML19 TRIAL
220021713 220005556 1.79 99.4 Disease modification (D) 1536-03-07 1536-03-08 Trial Unspecified 02 N 220021255 TRIAL
220021714 220012943 1.7 94.3 Curative (C) 2018-03-31 2018-04-04 Trial Unspecified 2 N 220021359 TRIAL
220021715 220005603 0 85.2 Curative (C) 2018-02-24 2018-05-04 AML 19 TRIAL N N 220021394 AML19 TRIAL
220021716 220005607 1.72 68.7 Curative (C) 2014-07-19 2017-02-18 AML 19 TRIAL Y N 220021411 AML19 TRIAL
220021717 220019406 1.49 98 Curative (C) 2016-02-20 2016-02-21 AML 19 TRIAL N N 220021453 AML19 TRIAL
220021718 220005634 1.87 63.9 Disease modification (D) 2019-04-07 2019-05-28 AML 19 TRIAL Y N 220021470 AML19 TRIAL
220021719 220005645 1.6 81.15 Curative (C) 2018-01-04 2018-03-25 AML 19 TRIAL N N 220021483 AML19 TRIAL
220021720 220017130 1.62 53.4 Curative (C) 2018-10-19 2018-10-19 Trial Unspecified 01 N 220021572 TRIAL
220021722 220012999 null 69.4 Curative (C) 2018-07-09 2018-07-09 AML 19 TRIAL 01 N 220021673 AML19 TRIAL
220021723 220020698 1.68 58.3 Curative (C) 2017-06-12 2017-10-01 AML 19 TRIAL Y N 220021690 AML19 TRIAL
220021724 220005722 1.56 null Curative (C) null 2018-12-17 Trial Unspecified 1 N 220021705 TRIAL
220021725 220005726 1.8 83 Curative (C) 2018-08-19 2018-11-27 Trial Unspecified Y N 220021721 TRIAL
220021726 220005760 1.72 74.6 Curative (C) 2017-08-19 2017-08-19 Trial Unspecified Y N 220021789 TRIAL
220021727 220013035 1.85 85.4 Curative (C) 2015-04-24 2015-05-05 AML 19 TRIAL Y null 220021792 AML19 TRIAL
220021728 220005772 1.66 107.5 null 2015-12-25 2015-12-25 Trial Unspecified Y N 220021810 TRIAL
220021730 220005808 1.94 71.4 Curative (C) 2019-04-26 2019-04-26 Trial Unspecified N N 220021942 TRIAL
220021731 220005820 1.77 99.6 Disease modification (D) 2014-04-11 2014-05-19 AML 19 TRIAL 01 N 220021958 AML19 TRIAL
220021732 220005825 1.49 107.5 Disease modification (D) 2014-02-12 2014-03-12 Trial Unspecified Y N 220021966 TRIAL
220021733 220005833 1.57 89.5 Disease modification (D) 2016-08-12 2016-08-17 Trial Unspecified Y N 220021995 TRIAL
220021734 220013101 1.73 84 Curative (C) 2016-07-10 2016-09-10 AML 19 TRIAL 01 N 220022059 AML19 TRIAL
220021735 220013105 1.69 62 Curative (C) 2016-06-18 2016-06-19 AML 19 TRIAL 1 N 220022092 AML19 TRIAL
220021736 220005872 1.72 74.8 Curative (C) 2014-11-21 2014-11-29 AML 19 TRIAL 1 N 220022122 AML19 TRIAL
220021737 220005879 1.78 76.1 null 2013-09-19 2013-09-22 Trial Unspecified Y N 220022138 TRIAL
220021738 220005887 null 58.8 Curative (C) 2014-05-08 2014-06-08 AML 19 TRIAL Y N 220022174 AML19 TRIAL
220021739 220005901 1.79 72.1 Adjuvant (A) 2014-07-17 2014-10-16 AML 19 TRIAL null N 220022212 AML19 TRIAL
220021740 220013166 1.56 63.4 Curative (C) 2016-06-04 2016-06-06 AML 19 TRIAL 01 null 220022379 AML19 TRIAL
220021741 220005969 1.72 68 null 2019-04-18 2019-04-18 Cytarabine Low Dose N N 220022475 CYTARABINE
220021742 220005974 null null Palliative (P) 2018-03-13 2018-03-17 Hydroxycarbamide 2 N 220022478 HYDROXYCARBAMIDE
220021743 220005992 1.52 0 Palliative (P) 2013-08-30 2014-12-15 Hydroxycarbamide 2 N 220022570 HYDROXYCARBAMIDE
220021744 220005993 1.56 67 Adjuvant (A) null 2015-06-27 Cytarabine Low Dose Y N 220022576 CYTARABINE
220021745 220017221 1.6 46.2 Curative (C) 2019-05-02 2019-06-03 Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYTARABINE + FLUDARABINE N N 220022595 NOT MATCHED
220021746 220006013 1.61 74 Disease modification (D) 2014-10-16 2015-02-05 Hydroxycarbamide 2 Y 220022645 HYDROXYCARBAMIDE
220021747 220013212 0 null Palliative (P) 2014-03-09 2014-03-26 Hydroxycarbamide 2 N 220022679 HYDROXYCARBAMIDE
220021749 220006026 null 12.8 Curative (C) 2014-07-14 2014-08-21 Amsacrine + BUSULFAN + CYTARABINE + FLUDARABINE 99 null 220022722 NOT MATCHED
220021750 220006047 1.79 62.8 Disease modification (D) 2013-10-30 2014-02-13 Hydroxycarbamide 02 N 220022807 HYDROXYCARBAMIDE
220021751 220006050 1.8 103 Palliative (P) null 2017-03-24 Hydroxycarbamide N N 220022827 HYDROXYCARBAMIDE